Argenx
ARGX
#579
Rank
ยฃ28.21 B
Marketcap
ยฃ461.48
Share price
0.77%
Change (1 day)
15.27%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: ยฃ28.21 Billion

As of November 2024 Argenx has a market cap of ยฃ28.21 Billion. This makes Argenx the world's 579th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ28.21 B59.31%
2023ยฃ17.71 B2.25%
2022ยฃ17.32 B27.16%
2021ยฃ13.62 B32.44%
2020ยฃ10.28 B96.11%
2019ยฃ5.24 B89.91%
2018ยฃ2.76 B86.2%
2017ยฃ1.48 B
2014ยฃ93.47 M

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Argenx was reported to be:

ยฃ27.59 Billion
by Yahoo Finance info icon info icon
ยฃ28.21 Billion
by CompaniesMarketCap info icon info icon
ยฃ27.31 Billion
by Nasdaq info icon info icon